Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

7X2L

Crystal structure of nanobody 3-2A2-4 with SARS-CoV-2 RBD

Summary for 7X2L
Entry DOI10.2210/pdb7x2l/pdb
DescriptorSpike protein S1, Nanobody 3-2A2-4, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose, ... (4 entities in total)
Functional Keywordssars-cov-2, nanobody, spike, receptor binding domain, viral protein-immune system complex, viral protein/immune system
Biological sourceSevere acute respiratory syndrome coronavirus 2 (2019-nCoV,SARS-CoV-2)
More
Total number of polymer chains2
Total formula weight36209.32
Authors
Wang, X.Q.,Zhang, L.Q.,Ren, Y.F.,Li, M.X. (deposition date: 2022-02-25, release date: 2022-12-07, Last modification date: 2023-11-29)
Primary citationLi, M.,Ren, Y.,Aw, Z.Q.,Chen, B.,Yang, Z.,Lei, Y.,Cheng, L.,Liang, Q.,Hong, J.,Yang, Y.,Chen, J.,Wong, Y.H.,Wei, J.,Shan, S.,Zhang, S.,Ge, J.,Wang, R.,Dong, J.Z.,Chen, Y.,Shi, X.,Zhang, Q.,Zhang, Z.,Chu, J.J.H.,Wang, X.,Zhang, L.
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses.
Nat Commun, 13:7957-7957, 2022
Cited by
PubMed: 36575191
DOI: 10.1038/s41467-022-35642-2
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.4 Å)
Structure validation

221716

PDB entries from 2024-06-26

PDB statisticsPDBj update infoContact PDBjnumon